Richard Stefanacci, DO, MGH, MBA, AGSF, CMD, discusses the unique opportunity clinical pathways have to improve the diagnosis of rare diseases, in addition to their role in treatment.
Richard Stefanacci, DO, MGH, MBA, AGSF, CMD, discusses the unique opportunity clinical pathways have to improve the diagnosis of rare diseases, in addition to their role in treatment.
Richard Stefanacci, DO, MGH,...